Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts.

Name: Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts.
Author: Póti, Ádám

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. — المؤلف: Póti, Ádám — British journal of cancer 20190911

المؤلف: Póti, Ádám
النشر: British journal of cancer 20190911
الوصف: 1392-1400 p.
الموضوعات: Antineoplastic Agents؛ Cell Line, Tumor؛ Female؛ Heterografts؛ Humans؛ Indazoles؛ Mutation؛ Piperidines